[Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
De Angelis
G
G
Divisione Pneumologica, Ospedale C. Forlanini, Roma.
De Marinis
F
F
Bigioni
D
D
Migliorino
M R
MR
Alma
M G
MG
Pigorini
F
F
D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood* / Q000401:mortality / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000097:blood* / Q000401:mortality / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000401:mortality / Q000473:pathology; D009367:Neoplasm Staging; D010455:Peptides / Q000097:blood; D010751:Phosphopyruvate Hydratase / Q000097:blood; D011379:Prognosis; D015996:Survival Rate; D013937:Thymidine Kinase / Q000097:blood; D019396:Tissue Polypeptide Antigen
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen; D013937:Thymidine Kinase; D010751:Phosphopyruvate Hydratase
Utilità dell'antigene carcinoembrionario (CEA), dell'antigene polipeptidico tessutale (TPA), dell'enolasi (NSE) e della timidina-kinasi (TK) nel monitoraggio e nella prognosi del carcinoma polmonare primitivo.